Healthcare Services

Global Bacterial Vaginosis Market Expected to Reach $5.12 Billion by 2030 with 9.1% CAGR

March 30, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Bacterial Vaginosis Market By 2030 Starting From Its 2026 Size?

The bacterial vaginosis market has experienced substantial expansion in recent years. It is anticipated to grow from $3.31 billion in 2025 to $3.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. The expansion observed in the historic period can be credited to various elements, including the increasing occurrence of bacterial vaginosis among women, improved access to gynecological healthcare services, the provision of both oral and topical antibiotics, the expansion of diagnostic laboratory services, and an increase in clinical screening initiatives.

The bacterial vaginosis market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a size of $5.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. The drivers behind this growth during the forecast period include the expanding creation of microbiome-based treatments, wider acceptance of swift molecular diagnostic tools, a heightened emphasis on women’s preventative health, the broadened availability of telehealth-aided diagnosis, and increased funding for non-antibiotic treatment options. Key trends expected in the same period involve a greater uptake of point-of-care diagnostic testing, an escalating need for specific antibiotic therapies, increased understanding of vaginal microbiome health, the proliferation of home-based testing methods, and a sharpened focus on early identification and screening.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

Which Market Drivers Are Supporting The Expansion Of The Bacterial Vaginosis Market?

The rising occurrence of sexually transmitted infections (STIs) is anticipated to propel the expansion of the bacterial vaginosis market in the future. Sexually transmitted infections (STIs) are defined as infections primarily transmitted through sexual contact, which can originate from bacteria, viruses, or parasites. The heightened incidence of STIs stems from factors such as unprotected sexual activity, having multiple partners, insufficient public awareness, and antibiotic resistance. Bacterial vaginosis elevates vulnerability to STIs by disrupting the natural bacterial equilibrium in the vagina, thereby facilitating the acquisition of infections like HIV and chlamydia. For example, data from the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government body, indicates that gonorrhea cases escalated from 70,881 in 2022 (17.9 per 100,000) to 96,969 in 2023 (25.0 per 100,000), representing a 31% year-on-year increase. Concurrently, syphilis cases grew from 35,391 in 2022 (8.5 per 100,000) to 41,051 in 2023 (9.9 per 100,000), a 13% rise. Furthermore, chlamydia notifications reached 230,199 in 2023, showing a 3% increase in the crude notification rate compared to 2022. Consequently, the escalating prevalence of sexually transmitted infections (STIs) is fueling the expansion of the bacterial vaginosis market.

Which Segment Categories Define The Bacterial Vaginosis Market?

The bacterial vaginosis market covered in this report is segmented –

1) By Type: Point-Of-Care Testing, Laboratory Testing

2) By Application: Diagnosis, Treatment, Recurrence Prevention Or Maintenance, Screening And Monitoring

3) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests

2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests

How Are Trends Shaping The Direction Of The Bacterial Vaginosis Market?

Leading firms in the bacterial vaginosis market are prioritizing the creation of novel solutions, including paired prescription regimens for sexual partners, to secure a competitive edge. These regimens entail providing treatment to both the infected person and their sexual partner, aiming to tackle the risk of recurrence directly. An example is Wisp, a U.S.-based women’s telehealth company, which introduced the pioneering Male BV Partner Treatment in March 2025. This treatment is a two-part prescription regimen specifically for male partners, consisting of oral metronidazole and topical clindamycin. Key features include synchronized dual treatment, daily administration over seven days, and distribution through Wisp’s telemedicine platform. This approach capitalizes on new clinical data to lower reinfection rates and strengthens the move towards more holistic, relationship-conscious care, despite potential increases in regulatory complexity and concerns regarding partner adherence.

Who Are The Top Companies Competing In The Bacterial Vaginosis Market?

Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Viatris Inc., Organon & Co., Shionogi & Company Limited, Otsuka Pharmaceutical Co. Ltd., Melinta Therapeutics Inc., Evofem Biosciences Inc., Gedea Biotech AB, Hologic Inc., bioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Roche Holding AG, Abbott Laboratories, Ferring Pharmaceuticals, Mylan N.V., Almirall S.A.

Read the full bacterial vaginosis market report here:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

How Is The Bacterial Vaginosis Market Distributed Across Key Geographic Regions?

North America was the largest region in the bacterial vaginosis market in 2025. The regions covered in the bacterial vaginosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bacterial Vaginosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

Browse Through More Reports Similar to the Global Bacterial Vaginosis Market 2026, By The Business Research Company

Bactericide Global Market Report

https://www.thebusinessresearchcompany.com/report/bactericide-global-market-report

Inhaled Antibiotics Global Market Report

https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report

Pneumococcal Vaccine Global Market Report

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795